Because of the reported statistical association between anticardiolipin antibodies and low complement concentrations3'4 we undertook this study to evaluate the complement fixation ability of these antibodies to try to explain their pathogenetic mechanism.
In the past few years growing attention has been focused on the association between the presence of anticardiolipin antibodies and habitual abortions, thrombosis, and thrombocytopenia, particularly in patients with systemic lupus erythematosus.' On the other hand, patients with infectious diseases may have anticardiolipin antibodies without these complications. 2 Little information is available about the pathogenetic role of these antibodies. A decrease in prostacyclin synthesis, binding to platelet membrane with its activation and inhibition of the fibrinolytic process are some of the proposed mechanisms for the clinical complications associated with anticardiolipin antibodies.
Because of the reported statistical association between anticardiolipin antibodies and low complement concentrations3'4 we undertook this study to evaluate the complement fixation ability of these antibodies to try to explain their pathogenetic mechanism. 
